Orano Med News and Activities

Orano Med is owned by Areva SA. Areva SA has a direct presence in 3 countries.

Areva SA has 4 subsidiaries including Orano, Orano China and Orano Med.

They are in:

• Energy80%
• Biotechnology20%

View the org chart displaying its 21 main executives

Most searched biographies at Orano Med

• Frederic Desdouits, Chief Executive Officer
• Simon Segal, Director
• Michael Mcmurphy, Director

Popular executive movements at Orano Med

• Frederic Desdouits, who was Director, is promoted to Chief Executive Officer  (posted on April 8 2026).

Create your alert
to follow the executive moves at Orano Med.

Areva SA has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
• Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
• Tissium has just announced a $60 Million fundraising (posted on July 8 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Orano Med

• Orano Med lays foundations for its new facility to produce precursors for its future lead-212 radioligand therapies

Social media about Orano Med

• Orano Med on Wikipedia, Google News & Yahoo Finance
• Orano Med on LinkedIn, X (Twitter) & YouTube